Description:

The study should evaluate the biological distribution of [177Lu]Lu-BQ7876 in patients with prostate cancer. The objective are: To evaluate the content of [177Lu]Lu-BQ7876 in the blood of patients with prostate cancer at different time points after a single intravenous administration. To assess the distribution of [177Lu]Lu-BQ7876 in normal tissues and tumors at different time points. To evaluate dosimetry of [177Lu]Lu-BQ7876. To study the safety and tolerability of the drug [177Lu]Lu-BQ7876 after a single injection.